SG scientists use AI platform to improve effectiveness of Covid-19 drugs against Omicron


Prof Ho and his team used IDentif.AI and explored different combinations and the most precise dosing needed, to amplify the effects of both molnupiravir and Paxlovid against Omicron. — AZMAN GHANI/The Star

SINGAPORE: Researchers in Singapore are hoping artificial intelligence (AI) can help better fight Covid-19 infections, with AI determining the most optimal combination of antiviral drugs and the correct dosing.

A recent study led by Professor Dean Ho, director of the Institute for Digital Medicine at the NUS Yong Loo Lin School of Medicine, has shown some promise.

Subscribe now and get 30% off The Star Yearly Plan

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.


Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Others Also Read


Want to listen to full audio?

Unlock unlimited access to enjoy personalise features on the TheStar.com.my

Already a subscriber? Log In